Hirschowitz B I
Division of Gastroenterology, University of Alabama at Birmingham 35294, USA.
Dig Dis Sci. 1996 Jul;41(7):1384-91. doi: 10.1007/BF02088563.
The objective of this study was to determine whether gastric secretion of acid and pepsin is different in the subset of esophagitis patients who also have Barrett's esophagus. Basal and stimulated gastric secretions were studied for 1 hr in the unstimulated state and 1 hr after pentagastrin 6 microg/kg subcutaneous injection. Because Barrett's patients are predominantly male, the 30 patients were matched with patients who had esophagitis, but not Barrett's, for sex (26 men, 4 women) and age as well as for background gastrointestinal disease (duodenal ulcer in 10, no ulcer disease in 17 and Zollinger-Ellison hypersecretors in 3). Patients with Barrett's weighed more than controls (P < 0.05). Acid and pepsin output in the basal and stimulated state were no different in Barrett's and their appropriately matched controls. Overnight fasting residue--volume, pH, acid and pepsin concentrations, and bile content--were also alike. The severity of esophagitis or prevalence of esophageal ulcer or stricture was not different between those with and without Barrett's and in neither was the grade of esophagitis related to acid or pepsin output. It is concluded that Barrett's esophagus patients do not have gastric secretions different from appropriately matched controls with esophagitis alone. When present, esophagitis due to reflux in Barrett's epithelium should be treated on its merits by appropriate reduction of acid exposure.
本研究的目的是确定在同时患有巴雷特食管的食管炎患者亚组中,胃酸和胃蛋白酶的分泌是否存在差异。在未刺激状态下对基础和刺激后的胃分泌进行1小时研究,并在皮下注射6微克/千克的五肽胃泌素1小时后再次进行研究。由于巴雷特食管患者以男性为主,30例患者在性别(26名男性,4名女性)、年龄以及背景胃肠道疾病方面(10例十二指肠溃疡,17例无溃疡疾病,3例佐林格-埃利森综合征高分泌者)与患有食管炎但无巴雷特食管的患者进行了匹配。巴雷特食管患者的体重高于对照组(P<0.05)。巴雷特食管患者及其匹配的对照组在基础和刺激状态下的酸和胃蛋白酶分泌量没有差异。过夜禁食后的残留物——体积、pH值、酸和胃蛋白酶浓度以及胆汁含量——也相似。有或无巴雷特食管的患者之间食管炎的严重程度、食管溃疡或狭窄的患病率没有差异,食管炎的分级也与酸或胃蛋白酶分泌量无关。结论是,巴雷特食管患者的胃分泌与仅患有食管炎的匹配对照组没有差异。当出现巴雷特上皮反流性食管炎时,应根据具体情况通过适当减少酸暴露进行治疗。